Who Paid My Doc
Christina Parisi
Obesity Medicine Columbia, MD Medical Doctor
NPI 1811274848 CMS profile 2777129
8850 Stanford Blvd Ste 2400, Columbia, MD 21045
General payments
$8,805
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Christina Parisi of Columbia, MD is reported in the CMS Open Payments database as having received $8,805 across 17 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $8,585 | 12 | |
| 2024 | General | $120 | 4 | |
| 2022 | General | $100 | 1 |
Beside peers
- Christina Parisi
- Obesity Medicine median
- Middle half of Obesity Medicine
- National median
In program year 2025, general payments to Christina Parisi were reported at $8,585. Among 30 Obesity Medicine profiles paid that year, the median was $190 and the middle half received between $125 and $2,258.
Show as a table
| Year | Christina Parisi | Obesity Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $128 | $31–$684 | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | $140 | $105–$307 | $132 |
| 2022 | $100 | $94 | $36–$376 | $149 |
| 2023 | $0 | $118 | $44–$1,006 | $160 |
| 2024 | $120 | $122 | $75–$730 | $164 |
| 2025 | $8,585 | $190 | $125–$2,258 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 7 billing codesPaid by Medicare
$8,318
Medicare patients
58
Services billed
103
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 53% | |
| Heart failure | 47% | |
| Depression | 47% | |
| Chronic kidney disease | 41% | |
| Ischemic heart disease | 38% | |
| Diabetes | 34% | |
| COPD | 33% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Payments and prescribing
1 product · payments 2024Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.
| Product | Paid by | Related payments | Part D claims | Part B services |
|---|---|---|---|---|
| ZEPBOUND |
|
$45 | — | — |
A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.
Records
17 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Obesity Medicine in Maryland
Related records
Obesity Medicine in Maryland
Practitioners in the same specialty and state, ranked by reported value.
All Obesity Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Maryland
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.